Changes in treatment pattern and costs in advanced hepatocellular carcinoma (HCC)-Reference-Cited by-同舟云学术

Changes in treatment pattern and costs in advanced hepatocellular carcinoma (HCC)

Published:2021-09-06 Issue:1 Volume:22 Page:147-154
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Muszbek Noemi¹,Evans Rachel²,Remak Edit³,Brennan Victoria K⁴,Colaone Fabien⁴,Shergill Suki⁴,Ross Paul⁵,Mullan Damian⁶

Affiliation:

1. Visible Analytics, Reading, UK

2. Visible Analytics, Oxford, UK

3. Visible Analytics, Budapest, Hungary

4. Health Economics, Pricing, Reimbursement & Market Access, SIRTEX Medical United Kingdom Ltd, London, UK

5. Department of Medical Oncology, Guy’s & St Thomas’ Nhs Foundation Trust, London, UK

6. Department of Radiology, The Christie NHS Foundation Trust, Manchester, UK

Funder

Sirtex Medical

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2021.1973892

Reference31 articles.

1. World Health Organization. CANCER TODAY: estimated number of new cases in 2018, worldwide, both sexes, all ages [internet]. 2020. [cited 2020 Feb 6]. Available from: http://gco.iarc.fr/today/home.

2. Cancer Research UK. Liver cancer incidence statistics [internet]. Cancer Research UK. 2015. [cited 2020 Feb 6]. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/liver-cancer/incidence.

3. Hepatocellular Carcinoma

4. Time and deprivation trends in incidence of primary liver cancer subtypes in England

5. EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness of Hepatocellular Carcinoma Surveillance Strategies in Patients With Compensated Liver Cirrhosis in the United Kingdom;Value in Health;2024-08

2. Designing of Novel Quinolines Derivatives as Hepatocellular Carcinoma Inhibitors by Using In silico Approaches;Biointerface Research in Applied Chemistry;2022-06-05